AJU IB Investment Co., Ltd.
Filing Date
Global Rank
#8,730
/ 8,788
▲ 29
· as of Mar 2026
Top Industry
Biotechnology
100.0%
Period ended 5 months ago
Filed May 8, 2026 · 4mo
14 quarters · since Dec 2020
Portfolio Concentration
6 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
34.9%
−1.8 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
2,556
Highly concentrated−354
Portfolio Trend
14 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $4,691,205 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
6 tracked positions ·
$4,691,205 total
· filing declares
6 positions · $30,523,310
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Held | 19,648 | $1,636,481 | 34.88% | |
| SEER |
Seer, Inc.
Healthcare
|
Held | 816,375 | $1,371,510 | 29.24% | |
| RLYB |
Rallybio Corp
Healthcare
|
Reduced | 94,334 | $846,175 | 18.04% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
Held | 17,500 | $435,925 | 9.29% | |
| XLO |
Xilio Therapeutics, Inc.
Healthcare
|
Reduced | 47,695 | $401,114 | 8.55% | |
|
|
Held | 223,486 | $0 | 0.00% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.